Patrick Lizotte, PhD

Prior to receiving his degree in cancer immunology at the Geisel School of Medicine at Dartmouth College, Dr. Lizotte  was at the Broad Institute conducting genome-wide synthetic lethal screens in oncology models. His research expertise is in immune-oncology target and biomarker identification, and development of novel immunotherapeutics.